 | Up a level |
Das, Shampa 
ORCID: 0000-0002-2540-4816, Li, Jianguo, Iaconis, Joseph, Zhou, Diansong, Stone, Gregory G, Yan, Jean Li and Melnick, David
(2019)
Ceftaroline fosamil doses and b breakpoints for <i>Staphylococcus aureus</i> in complicated skin and soft tissue infections.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 74 (2).
pp. 425-431.
Corey, G Ralph, Wilcox, Mark H, Gonzalez, Jesus, Jandourek, Alena, Wilson, David J, Friedland, H David, Das, Shampa ORCID: 0000-0002-2540-4816, Iaconis, Joseph and Dryden, Matthew
(2019)
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 53 (6).
pp. 830-837.
Cristinacce, Andrew, Wright, James G, Macpherson, Merran, Iaconis, Joseph and Das, Shampa ORCID: 0000-0002-2540-4816
(2021)
Comparing probability of target attainment against <i>Staphylococcus aureus</i> for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using pharmacokinetic/pharmacodynamic models.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 99 (4).
115292-.